What is Torpac?
Torpac specializes in the production of a diverse range of capsules, including veterinary capsules, soluble containers, and gelatin capsules, alongside specialized rat capsules. The company also provides essential capsule fillers and encapsulators, catering to the specific needs of clients within the veterinary and pharmaceutical sectors. Torpac's core mission is to deliver effective encapsulation and medication delivery solutions, positioning itself as a key supplier for industries requiring precise formulation and packaging.
How much funding has Torpac raised?
Torpac has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Torpac
PPP
Public-Private Partnership
What's next for Torpac?
With a substantial large-scale, late-stage funding round, Torpac is strategically positioned to enhance its production capabilities and potentially broaden its product portfolio. The recent strategic investment indicates confidence from backers in Torpac's business model and its capacity for sustained growth. Future developments may include expanding its market reach, investing in research and development for novel encapsulation technologies, or forging new partnerships within the pharmaceutical and veterinary supply chains. This capital infusion is expected to fuel operational enhancements and solidify its competitive advantage.
See full Torpac company page
